<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="85495">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01669850</url>
  </required_header>
  <id_info>
    <org_study_id>2-12-07-002</org_study_id>
    <nct_id>NCT01669850</nct_id>
  </id_info>
  <brief_title>Clipped Versus Handsewn Arteriovenous Fistula Anastomosis</brief_title>
  <official_title>The Safety and Effectiveness of Clipped Technique vs. Hand-Sewn Technique for Anastomosis in Arteriovenous Fistulas</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gundersen Lutheran Medical Foundation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Gundersen Lutheran Health System</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Gundersen Lutheran Medical Foundation</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <authority>United States: Gundersen Lutheran HSC/IRB</authority>
    <authority>United States: Gundersen Lutheran Medical Research Dept.</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether handsewn anastomosis versus clipped
      technique is associated with more complications, fistula failures, surgical cost and
      surgical time.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      End stage renal disease requiring hemodialysis has become more prevalent in recent years.
      Achieving vascular access is an important step in receiving hemodialysis. Recent national
      goals have established that approximately 65% of all dialysis access points should be
      arteriovenous fistulas due to higher patency rates and decreased rates of further surgeries.
      Multiple studies have been done to assess optimal suture technique for arteriovenous
      anastomoses. The use of clips versus a handsewn technique has been evaluated in
      retrospective studies with some reports indicating a higher primary patency rate with a clip
      technique.  Further study is needed to definitively determine the technique that results in
      the highest patency rates and lowest rate of re-operation. The purpose of this study is to
      determine whether hand-sewn anastomosis versus a clipped technique is associated with more
      complications, failures, surgical cost and surgical time by randomizing patients to either a
      clipped anastomosis group or a handsewn anastomosis group.
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date>August 2012</start_date>
  <primary_completion_date type="Anticipated">August 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Patency rates</measure>
    <time_frame>2 years postoperative</time_frame>
    <safety_issue>No</safety_issue>
    <description>Patency will be assessed and the fistula considered patent if it has been accessed for dialysis at least once, or based on clinical assessment with palpable thrill if dialysis access has not been attempted.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Surgical complications</measure>
    <time_frame>2 years postoperative</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Complications will be monitored intraoperatively, and postoperatively. These include any re-interventions, and wound complications, infection, hematoma, thrombosis , steal syndrome, distal ischemia.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Cost</measure>
    <time_frame>1 year postoperative</time_frame>
    <safety_issue>No</safety_issue>
    <description>Cost for the vascular clip device will be compared to cost of the handsewn technique.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Arteriovenous Fistula Complications and Failure</condition>
  <arm_group>
    <arm_group_label>Clipped anastomosis</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A vascular clip device will be used to create the anastomosis during arteriovenous fistula creation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Handsewn anastomosis</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>A handsewn technique will be used to create the anastomosis in arteriovenous fistula creation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Clipped anastomosis</intervention_name>
    <description>The vascular clip devise will be used to complete the anastomosis during fistula creation.</description>
    <arm_group_label>Clipped anastomosis</arm_group_label>
    <other_name>Anastoclip (Le Maitre)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Handsewn anastomosis</intervention_name>
    <description>a handsewn anastomosis technique will be used during fistula creation.</description>
    <arm_group_label>Handsewn anastomosis</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 years of age or older.

          -  Need for AVF creation for vascular access for planned hemodialysis (within 1 year).

          -  The planned AVF site must be na√Øve of prior AVF creations.

          -  Vein mapping studies completed

          -  2.5 - 3mm minimum vein diameter on mapping

        Exclusion Criteria:

          -  Less than 18 years of age.

          -  Inability to provide consent.

          -  Previous failed AVFs in both arms.

          -  Contraindications to AVF creation:

               -  ipsilateral proximal venous and arterial occlusion or stenosis

               -  systemic or local infection

               -  too ill to operate

          -  Anticipated inability to keep 30-day postoperative follow-up appointment.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Clark A Davis, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Gundersen Lutheran Health System</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Gundersen Lutheran Health System</name>
      <address>
        <city>La Crosse</city>
        <state>Wisconsin</state>
        <zip>54601</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Baguneid MS, Goldner S, Fulford PE, Hamilton G, Walker MG, Seifalian AM. A comparison of para-anastomotic compliance profiles after vascular anastomosis: nonpenetrating clips versus standard sutures. J Vasc Surg. 2001 Apr;33(4):812-20.</citation>
    <PMID>11296337</PMID>
  </reference>
  <reference>
    <citation>Lin PH, Bush RL, Nelson JC, Lam R, Paladugu R, Chen C, Quinn G, Lumsden AB. A prospective evaluation of interrupted nitinol surgical clips in arteriovenous fistula for hemodialysis. Am J Surg. 2003 Dec;186(6):625-30.</citation>
    <PMID>14672769</PMID>
  </reference>
  <reference>
    <citation>Varcoe RL, Teo AB, Pelletier MH, Yu Y, Yang JL, Crowe PJ, Walsh WR. An arteriovenous fistula model of intimal hyperplasia for evaluation of a nitinol U-Clip anastomosis. Eur J Vasc Endovasc Surg. 2012 Feb;43(2):224-31. doi: 10.1016/j.ejvs.2011.11.002. Epub 2011 Nov 21.</citation>
    <PMID>22104322</PMID>
  </reference>
  <reference>
    <citation>Shenoy S, Miller A, Petersen F, Kirsch WM, Konkin T, Kim P, Dickson C, Schild AF, Stewart L, Reyes M, Anton L, Woodward RS. A multicenter study of permanent hemodialysis access patency: beneficial effect of clipped vascular anastomotic technique. J Vasc Surg. 2003 Aug;38(2):229-35.</citation>
    <PMID>12891102</PMID>
  </reference>
  <reference>
    <citation>Shenoy S, Woodward RS. Economic impact of the beneficial effect of changing vascular anastomotic technique in hemodialysis access. Vasc Endovascular Surg. 2005 Sep-Oct;39(5):437-43.</citation>
    <PMID>16193217</PMID>
  </reference>
  <verification_date>April 2013</verification_date>
  <lastchanged_date>April 11, 2013</lastchanged_date>
  <firstreceived_date>August 16, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Gundersen Lutheran Medical Foundation</investigator_affiliation>
    <investigator_full_name>Kara Kallies</investigator_full_name>
    <investigator_title>Advanced Research Associate, on behalf of Clark Davis, MD (PI)</investigator_title>
  </responsible_party>
  <keyword>Chronic kidney disease</keyword>
  <keyword>Arteriovenous fistula</keyword>
  <keyword>Surgical anastomosis</keyword>
  <keyword>Complications</keyword>
  <keyword>Patency</keyword>
  <keyword>Dialysis access</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Arteriovenous Fistula</mesh_term>
    <mesh_term>Fistula</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
